↓ Skip to main content

Empagliflozin in Patients with Chronic Kidney Disease

Overview of attention for article published in New England Journal of Medicine, November 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
69 news outlets
blogs
6 blogs
policy
1 policy source
twitter
1452 X users
facebook
9 Facebook pages
wikipedia
3 Wikipedia pages

Readers on

mendeley
556 Mendeley